REITs invest in the majority of real estate property types, including offices, apartment buildings, warehouses, retail centers, medical facilities, data centers, cell towers and hotels.
Nareit’s REIT Directory provides a comprehensive list of REIT and publicly traded real estate companies that are members of Nareit. The directory can be sorted and filtered by sector, listing status, and stock performance.
Each year Nareit collects tax reporting data for each Nareit member. View this year's data or explore the archive.
REITs delivered strong investment performance through mid-year 2026, outperforming the broad equity market by a sizable margin.
The REIT industry's premier annual conference, bringing together leaders for networking, one-on-one meetings, and insights shaping the year ahead.
For 65 years, Nareit has led the U.S. REIT industry by ensuring its members’ best interests are promoted by providing unparalleled advocacy, investor outreach, continuing education and networking.
Owen Thomas says research shows premiere workplaces have “extremely different” operating performance.
Trepp senior managing director Susan Persin expects IPO activity to be sustained.
RBC's John Perkins says private portfolios looking for liquidity.
Green Street's Lukas Hartwich discusses the state of the lodging sector.
The Feb. 28 panel focused on the growth of REITs in India and beyond.
LaSalle global real estate strategist discusses international developments.
CEO Thomas DeRosa discusses plans for REIT’s growth abroad.
CEO John Moragne says REIT is as defensively positioned as possible.
Join REIT sustainability experts from all over the country to advance the sustainability conversation.
Extra Space CEO Spencer Kirk highlights gains from operating platform and lack of new supply.
Michael Barnello of LaSalle Hotel Properties discusses trends in guests’ tastes and preferences.
CEO Sam Landy sees potential boost in vacant land value from administration policy.
HCP’s Justin Hutchens sees growth in senior housing, medical properties and life sciences.
Griffin Capital’s Kevin Shields says transparency broadening appeal of PNLRs to investors.